Research location
Córdoba
Cordoba, Spain
Advertisement
Research activity in Córdoba
Cordoba, SpainCureCurrent currently publishes aggregate city-level research activity for this location: 94 trials and 95 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Córdoba
57 linked trials · page 1 of 2Sarcopenia in Patients With Heart FailureNCT06634316 · 2024-11-15 · 1 site observation
ACTIVE_NOT_RECRUITING
Multi-omics in Severe Asthma From Olive Pollen AllergyNCT07721376 · 2024-10-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of MalnutritionNCT05913193 · 2023-12-15 · 1 site observation
COMPLETED
A Study to Evaluate the Impact of Liquid Biopsy in Participants With a Clinical Diagnosis of Advanced CancerNCT05846594 · 2023-09-14 · 1 site observation
COMPLETED
Effectiveness of Exergaming in Adittion to Conventional Treatment for Physical Therapy in People with Multiple SclerosisNCT06196866 · 2023-09-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%NCT05659563 · 2023-07-20 · 1 site observation
COMPLETED
Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast CancerNCT04733118 · 2021-08-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Mediterranean Diet and Nutritional Support in Heart Failure SarcopeniaNCT05848960 · 2021-07-01 · 1 site observation
COMPLETED
ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaLNCT04603183 · 2021-06-02 · 1 site observation
COMPLETED
A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid ArthritisNCT04497597 · 2020-10-16 · 1 site observation
COMPLETED
A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate CancerNCT03879122 · 2019-02-11 · 1 site observation
UNKNOWN
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast CancerNCT03493854 · 2018-06-14 · 1 site observation
COMPLETED
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast CancerNCT03337724 · 2018-01-06 · 1 site observation
COMPLETED
A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)NCT03285763 · 2017-10-25 · 1 site observation
COMPLETED
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane RegimenNCT03016312 · 2017-01-10 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Who Received Prior Trastuzumab and Taxane Based TherapyNCT02924883 · 2016-09-26 · 1 site observation
COMPLETED
Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)NCT02776072 · 2016-05-01 · 1 site observation
COMPLETED
A Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Participants With HER 2-Negative Aggressive Metastatic Breast CancerNCT02613208 · 2015-12-09 · 1 site observation
COMPLETED
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)NCT02425891 · 2015-06-23 · 1 site observation
COMPLETED
A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)NCT02273973 · 2014-11-12 · 1 site observation
COMPLETED
A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast CancerNCT02132949 · 2014-07-14 · 1 site observation
COMPLETED
Retrospective Study in a NSCLC M+ pNCT01795352 · 2013-03-01 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based TreatmentNCT01702571 · 2012-11-27 · 1 site observation
COMPLETED
An Observational Study in Clinical Practice Management of Patients With Biological Drugs in MonotherapyNCT01664117 · 2012-06-01 · 1 site observation
COMPLETED
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast CancerNCT01491737 · 2012-02-17 · 1 site observation
COMPLETED
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast CancerNCT01358877 · 2011-11-08 · 1 site observation
COMPLETED
Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast CancerNCT01401166 · 2011-10-01 · 1 site observation
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateNCT01399697 · 2011-09-01 · 1 site observation
COMPLETED
Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1NCT01345630 · 2011-09-01 · 1 site observation
TERMINATED
Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)NCT01284608 · 2011-03-01 · 1 site observation
COMPLETED
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA)NCT01250379 · 2011-02-01 · 1 site observation
COMPLETED
An Observational Study of Dosage Patterns in Routine Clinical Practice in Patients With Rheumatoid Arthritis (ACT-LIFE)NCT01338545 · 2010-07-01 · 1 site observation
COMPLETED
Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple SclerosisNCT01064401 · 2010-05-01 · 1 site observation
COMPLETED
Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)NCT01081496 · 2010-03-01 · 1 site observation
COMPLETED
A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast CancerNCT00976989 · 2009-11-01 · 1 site observation
COMPLETED
An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-InhibitorNCT01557348 · 2009-06-01 · 1 site observation
COMPLETED
Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With SchizophreniaNCT00873249 · 2009-04-01 · 1 site observation
COMPLETED
An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) TherapyNCT00883753 · 2009-03-01 · 1 site observation
COMPLETED
A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected PatientsNCT00827112 · 2009-03-01 · 1 site observation
COMPLETED
A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast CancerNCT00846027 · 2009-01-01 · 1 site observation
COMPLETED
Etravirine Plus 2 Analogs in HIV-infected PatientsNCT01437241 · 2009-01-01 · 1 site observation
COMPLETED
Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With LipoatrophyNCT00865007 · 2008-12-01 · 1 site observation
COMPLETED
Antidepressant Incomplete Response DepressionNCT00782964 · 2008-10-01 · 1 site observation
COMPLETED
An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.NCT00750880 · 2008-09-01 · 1 site observation
COMPLETED
Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma HistologyNCT00596830 · 2008-04-01 · 1 site observation
TERMINATED
A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.NCT00559754 · 2007-12-01 · 1 site observation
COMPLETED
Expanded Access Program for Maraviroc At Multiple CentersNCT00426660 · 2007-02-01 · 1 site observation
COMPLETED
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And CapecitabineNCT00373113 · 2006-11-01 · 1 site observation
TERMINATED
A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.NCT00391092 · 2006-09-01 · 1 site observation
COMPLETED
VENICE Study Nevirapine Full Dose/Dose EscalationNCT00704249 · 2006-07-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.